The study identifies a neutralization epitope in the central region of VP1 of the foot-and-mouth disease virus that is cleaved by trypsin and arginine-specific protease.
Answers are grounded in this paper and cite their sources.
Defines protease-sensitive neutralization epitope on FMDV VP1; leaves open its utility for vaccine or diagnostic design.
Neutralizing monoclonal antibodies raised against intact foot-and-mouth disease virus reacted with intact particles and with isolated VP1 from different strains from the same subtype. Prior treatment of the virus with either trypsin or with arginine-specific protease abolished recognition of both the virus and of VP1, suggesting the presence of a neutralization epitope in the central region of VP1 cleaved by these two enzymes. A synthetic peptide analogue of part of this region showed poor reactivity, however, with neutralizing antibody.
No takes yet. Share an insight, caveat, or question.
Duchesne et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: